Daratumumab(Darzalex) is a human IgG1κ monoclonal antibody (mAb) that binds to the CD38 protein expressed on the surface of cells in a variety of hematological malignancies, including clonal plasma cells in multiple myeloma and AL amyloidosis, as well as in other cell and tissue types. Here, CD38 is linked to AL amyloidosis.